相似文献
1
Ras, ROS and proteotoxic stress: a delicate balance.
Cancer Cell. 2011 Sep 13;20(3):281-2. doi: 10.1016/j.ccr.2011.08.020.
2
Thiostrepton suppresses colorectal cancer progression through reactive oxygen species related endoplasmic reticulum stress.
Toxicol Appl Pharmacol. 2025 Feb;495:117221. doi: 10.1016/j.taap.2024.117221. Epub 2024 Dec 27.
3
A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3.
Mol Cell Biol. 2015 Nov;35(21):3646-56. doi: 10.1128/MCB.00541-15. Epub 2015 Aug 17.
4
Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis.
Cell Death Dis. 2021 Feb 16;12(2):189. doi: 10.1038/s41419-021-03473-6.
5
Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin.
Oncogene. 2003 Mar 6;22(9):1349-57. doi: 10.1038/sj.onc.1206289.
6
Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes.
J Immunol. 2004 Jul 15;173(2):920-31. doi: 10.4049/jimmunol.173.2.920.
7
Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells.
J Cancer Res Clin Oncol. 2011 Mar;137(3):471-80. doi: 10.1007/s00432-010-0910-z. Epub 2010 May 15.
8
Proteotoxic Stress and Cell Death in Cancer Cells.
Cancers (Basel). 2020 Aug 23;12(9):2385. doi: 10.3390/cancers12092385.
9
Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
ACS Appl Mater Interfaces. 2019 Jul 31;11(30):26722-26730. doi: 10.1021/acsami.9b09784. Epub 2019 Jul 18.
10
Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress.
Mol Oncol. 2015 Mar;9(3):601-16. doi: 10.1016/j.molonc.2014.11.001. Epub 2014 Nov 15.
引用本文的文献
1
Pincer-Type Pt(II)-NHC Antibody-Drug Conjugate for HER-2-Targeted Chemoimmunotherapy.
Adv Healthc Mater. 2025 Apr;14(9):e2403449. doi: 10.1002/adhm.202403449. Epub 2025 Feb 14.
2
Simvastatin, Its Antimicrobial Activity and Its Prevention of Alzheimer's Disease.
Microorganisms. 2024 Jun 1;12(6):1133. doi: 10.3390/microorganisms12061133.
3
Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.
Cancers (Basel). 2022 Feb 4;14(3):802. doi: 10.3390/cancers14030802.
4
Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers.
J Pers Med. 2021 Feb 2;11(2):92. doi: 10.3390/jpm11020092.
5
Oncogenic Ras downregulates expression through generation of reactive oxygen species.
Korean J Physiol Pharmacol. 2020 May 1;24(3):267-276. doi: 10.4196/kjpp.2020.24.3.267.
6
Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light.
Photochem Photobiol Sci. 2019 Aug 1;18(8):1877-1909. doi: 10.1039/c9pp00089e. Epub 2019 Jun 11.
7
Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics.
Redox Biol. 2019 Jul;25:101124. doi: 10.1016/j.redox.2019.101124. Epub 2019 Jan 25.
8
HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells.
Oncogene. 2018 Aug;37(32):4413-4427. doi: 10.1038/s41388-018-0227-y. Epub 2018 May 3.
9
Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective.
PLoS Comput Biol. 2017 Feb 6;13(2):e1005352. doi: 10.1371/journal.pcbi.1005352. eCollection 2017 Feb.
10
Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Oncotarget. 2016 Oct 18;7(42):68044-68056. doi: 10.18632/oncotarget.11172.
本文引用的文献
1
Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxia-induced injury in H9c2 cardiac myocytes.
Int J Mol Med. 2011 Sep;28(3):397-403. doi: 10.3892/ijmm.2011.682. Epub 2011 Apr 20.
2
New druggable targets in the Ras pathway?
Curr Opin Mol Ther. 2010 Dec;12(6):674-83.
3
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8788-93. doi: 10.1073/pnas.1003428107. Epub 2010 Apr 26.
4
Clinical and genetic aspects of neurofibromatosis 1.
Genet Med. 2010 Jan;12(1):1-11. doi: 10.1097/GIM.0b013e3181bf15e3.
5
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.
J Clin Invest. 2009 Jun;119(6):1727-40. doi: 10.1172/JCI37127. Epub 2009 May 18.
6
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.
Oncogene. 2007 May 14;26(22):3227-39. doi: 10.1038/sj.onc.1210414.
7
Suppression of the mTOR-raptor signaling pathway by the inhibitor of heat shock protein 90 geldanamycin.
J Biochem. 2006 Jan;139(1):129-35. doi: 10.1093/jb/mvj008.
8
Targeting RAS signalling pathways in cancer therapy.
Nat Rev Cancer. 2003 Jan;3(1):11-22. doi: 10.1038/nrc969.
9
Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha.
Mol Cell Biol. 2002 Dec;22(24):8506-13. doi: 10.1128/MCB.22.24.8506-8513.2002.
Zotero 插件